Your browser doesn't support javascript.
loading
Treatment of allosensitized patients receiving allogeneic transplantation.
Ciurea, Stefan O; Al Malki, Monzr M; Kongtim, Piyanuch; Zou, Jun; Aung, Fleur M; Rondon, Gabriela; Chen, Julianne; Taniguchi, Michiko; Otoukesh, Salman; Nademanee, Auayporn; Forman, Stephen J; Champlin, Richard; Gendzekhadze, Ketevan; Cao, Kai.
Afiliación
  • Ciurea SO; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Al Malki MM; Hematopoietic Cell Transplantation and Cellular Therapy Program, Division of Hematology-Oncology, The University of California Irvine, Irvine, CA.
  • Kongtim P; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
  • Zou J; Hematopoietic Cell Transplantation and Cellular Therapy Program, Division of Hematology-Oncology, The University of California Irvine, Irvine, CA.
  • Aung FM; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
  • Rondon G; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
  • Chen J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Taniguchi M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Otoukesh S; HLA Laboratory, City of Hope, Duarte, CA.
  • Nademanee A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
  • Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
  • Champlin R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
  • Gendzekhadze K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Cao K; HLA Laboratory, City of Hope, Duarte, CA.
Blood Adv ; 5(20): 4031-4043, 2021 10 26.
Article en En | MEDLINE | ID: mdl-34474478
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prevenibles Asunto principal: Trasplante de Células Madre Hematopoyéticas / Antígenos HLA Tipo de estudio: Guideline Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prevenibles Asunto principal: Trasplante de Células Madre Hematopoyéticas / Antígenos HLA Tipo de estudio: Guideline Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Año: 2021 Tipo del documento: Article